Pay in 4 interest-free payments of $5.88 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
This reassures clinicians that strict BP control can be achieved without worsening glycaemic outcomes, provided appropriate monitoring is in place
The difference emerged during follow-up beyond six months, and no significant difference between the two drugs was established for cardiovascular disease risk, although the limited number of cardiovascular events reduced the precision of these estimates
C Csaba Verified user Verified user on July 29, 2026 551 Fast handling and good follow-up A Anne Verified user Verified user on July 28, 2026 Read more about Mounjaro Further reading Take a look at our helpful health guides related to weight loss
Aetna plans will typically classify drugs into multiple tiers, including generic, preferred brand, non-preferred brand, preferred specialty, non-preferred specialty, and non-formulary
The SELECT trial (2023) demonstrated a 20% reduction in major adverse cardiovascular events in non-diabetic obese patients establishing cardiovascular research as a major frontier for GLP-1 agonist compounds
